Concepedia

Deon Hildebrand

DH

Statistics

Publications

3

Citations

131

H-Index

3

Active since

2014

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Pfizer (United States)

Amgen (United States)

Deon Hildebrand is an author at GlaxoSmithKline (United Kingdom) specializing in toxicology, toxicokinetics, and immunology.

Publications per year

2014–2024

3

Publications

3

Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses

Ben Forbes, Raegan O’Lone, Philippa Pribul Allen et al. · Advanced Drug Delivery Reviews · 2014 · 91 citations · Full text

, , +17

The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019)

Vanessa Schumacher, Famke Aeffner, Erio Barale-Thomas et al. · Toxicologic Pathology · 2020 · 20 citations

, , +10

N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulations

Anthony M Lynch, Jonathan Howe, Deon Hildebrand et al. · Mutagenesis · 2024 · 20 citations · Full text

, , +15

1–3 of 3